Evidence map›Paper›PMID 40140006›Full record

Observational studyEuropean archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery2025

Nasal cytological evidence of chronic inflammation in the olfactory cleft in post-viral olfactory dysfunction.

Gianluca Velletrani, Denise Fiorelli, Beatrice Francavilla, Marzia Nuccetelli, Sergio Bernardini, Simonetta Masieri, Stefano Di Girolamo

Abstract readObservational Study
In one paragraph

Observational study in European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Gianluca Velletrani *Department of Otorhinolaryngology, University of Rome "Tor Vergata", Rome, 00133, Italy.ORCID http://orcid.org/0000-0002-0822-6587
Denise Fiorelli *Department of Experimental Medicine, University of "Tor Vergata", Rome, 00133, Italy.ORCID http://orcid.org/0000-0001-6910-6995
Beatrice Francavilla *Department of Otorhinolaryngology, University of Rome "Tor Vergata", Rome, 00133, Italy. beatrice.francavilla@ptvonline.it.ORCID http://orcid.org/0000-0002-4788-7310
Marzia NuccetelliDepartment of Experimental Medicine, University of "Tor Vergata", Rome, 00133, Italy.ORCID http://orcid.org/0000-0002-8702-1116
Sergio BernardiniDepartment of Experimental Medicine, University of "Tor Vergata", Rome, 00133, Italy.ORCID http://orcid.org/0000-0003-1984-6834
Simonetta MasieriDepartment of Oral and Maxillofacial Sciences, Sapienza University, Rome, 00185, Italy.ORCID http://orcid.org/0000-0003-0423-9505
Stefano Di GirolamoDepartment of Otorhinolaryngology, University of Rome "Tor Vergata", Rome, 00133, Italy.ORCID http://orcid.org/0000-0002-6419-9704

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThis study investigated nasal cytological alterations in patients with persistent post-viral olfactory dysfunction. The primary objective was to evaluate the role of immune dysregulation and chronic local inflammation within the nasal mucosa in sustaining long-term olfactory impairment.

methodsAn observational case-control study was conducted at the Otorhinolaryngology Department of the University of Rome Tor Vergata. Thirty-six patients with persistent olfactory dysfunction were compared to two control groups: one comprised subjects recovered from SARS-CoV-2 infection without olfactory impairment, and the other included individuals without a history of COVID-19 or olfactory dysfunction. Psychophysical olfactory function was assessed using the TDI (Threshold, Discrimination, and Identification) test. Nasal cytology samples were obtained via nasal brushing at the level of the olfactory cleft and stained using the May-Grunwald-Giemsa technique. Cellular alterations were evaluated using a semiquantitative grading system.

resultsPatients with persistent olfactory dysfunction exhibited increased lymphocytes and neutrophils compared to both control groups, indicating ongoing local inflammation. Ciliocytophthoria was notably present in a significant portion of the olfactory dysfunction group, while absent or minimally present in controls. Eosinophils and mast cells were rare across all groups.

conclusionPersistent post-viral olfactory dysfunction is associated with sustained immune activation and epithelial damage localized to the olfactory cleft. Elevated lymphocytes, neutrophils, and ciliocytophthoria emphasize the role of chronic inflammation in the pathogenesis of prolonged olfactory deficits. These findings highlight the potential utility of targeted therapies to modulate immune responses and promote olfactory recovery in affected patients.

Indexed as

COVID-19Nasal MucosaOlfaction DisordersAdultAgedCase-Control StudiesChronic DiseaseFemaleHumansInflammationLymphocytesMaleMiddle AgedNeutrophilsSARS-CoV-2CiliocytophthoriaLong COVIDLymphocytesNasal cytologyOlfactory dysfunctionPost-Viral

Identifiers

PMID40140006
PMCPMC12055885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.